| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000026209 |
| Receipt No. | R000030106 |
| Official scientific title of the study | Prospective investigation of the relationship between plasma cardiac biomarkers(Neprilysin, pro BNP, ANP and BNP) and pathology of patients with chronic heart failure |
| Date of disclosure of the study information | 2017/03/01 |
| Last modified on | 2017/04/01 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Prospective investigation of the relationship between plasma cardiac biomarkers(Neprilysin, pro BNP, ANP and BNP) and pathology of patients with chronic heart failure | |
| Title of the study (Brief title) | Prospective investigation of the relationship between plasma cardiac biomarkers(Neprilysin, pro BNP, ANP and BNP) and pathology of patients with chronic heart failure | |
| Region |
|
|
| Condition | |||
| Condition | heart failure | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the relationship between plasma cardiac biomarkers(Neprilysin, pro BNP, ANP and BNP) and pathology of patients with chronic heart failure |
| Basic objectives2 | Others |
| Basic objectives -Others | To make use of the results to the clinical medicine |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | plasma cardiac biomarkers(Neprilysin, pro BNP, ANP and BNP) |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (a)Patients whose main or deputy name of disease are chronic heart failure or healthy control group who are willing to take part in this study
(b)Age more than 20 years and under 85 years (c)Patients or control group from whom a written informed consent was obtained |
|||
| Key exclusion criteria | (a)Patients received investigational new drugs within six months
(b)Patients with non-cardiac or non-renal disease(such as a malignancy, serious infection, and so on) and their prognoses are less than one year (c)Patients with renal insufficiency (eGFR< 30 ml/min/1.73m2) or on maintenance dialysis (d)Patients who is not suitable to this study due to medical reasons |
|||
| Target sample size | 140 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroshi Ito |
| Organization | Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences |
| Division name | Cardiovascular Medicine |
| Address | 2-5-1, Shikata-cho, Kita-ku, Okayama |
| TEL | 086-235-7351 |
| itomd@md.okayama-u.ac.jp | |
| Public contact | |
| Name of contact person | Norifumi Kawakita |
| Organization | Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences |
| Division name | Cardiovascular Medicine |
| Address | 2-5-1 Shikada-cho Kita-ku Okayama |
| TEL | 086-235-7351 |
| Homepage URL | |
| rm3ta6@bma.biglobe.ne.jp | |
| Sponsor | |
| Institute | Cardiovascular Medicine
Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Cardiovascular Medicine
Okayama University Graduate School of. Medicine, Dentistry and Pharmaceutical Sciences |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Based on the results, we'll also take the intervention test into account |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030106 |